These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 310364
41. Modifications to indirect immunofluorescence tests on Lassa, Marburg, and Ebola material. van der Groen G, Kurata T, Mets C. Lancet; 1983 Mar 19; 1(8325):654. PubMed ID: 6131336 [No Abstract] [Full Text] [Related]
42. [A comparative study of the immunological indices in guinea pigs administered an inactivated Marburg virus]. Ignat'ev GM, Agafonov AP, Strel'tsova MA, Kuz'min VA, Maĭnagasheva GI, Spirin GV, Chernyĭ NB. Vopr Virusol; 1991 Mar 19; 36(5):421-3. PubMed ID: 1803779 [Abstract] [Full Text] [Related]
43. A consideration of the diagnosis of dangerous infectious fevers in South Africa. Gear JH, Ryan J, Rossouw E. S Afr Med J; 1978 Feb 18; 53(7):235-7. PubMed ID: 565951 [No Abstract] [Full Text] [Related]
44. [Assay for level of Marburg virus in blood and isolates from experimentally infected animals]. Chupurnova TS, Pisanko VA, Bakulina LF, Zhukov VA, Chepurnov AA. Vopr Virusol; 2000 Feb 18; 45(2):18-20. PubMed ID: 10765545 [Abstract] [Full Text] [Related]
45. Experimental respiratory Marburg virus haemorrhagic fever infection in the common marmoset (Callithrix jacchus). Smither SJ, Nelson M, Eastaugh L, Laws TR, Taylor C, Smith SA, Salguero FJ, Lever MS. Int J Exp Pathol; 2013 Apr 18; 94(2):156-68. PubMed ID: 23441639 [Abstract] [Full Text] [Related]
46. [The detection of the Marburg virus antigen by solid-phase immunoenzyme analysis]. Vladyko AS, Chepurnov AA, Bystrova SI, Lemeshko NN, Lukashevich IS. Vopr Virusol; 1991 Apr 18; 36(5):419-21. PubMed ID: 1725078 [Abstract] [Full Text] [Related]
47. [A case of a laboratory infection with Marburg fever]. Nikiforov VV, Turovskiĭ IuI, Kalinin PP, Akinfeeva LA, Katkova LR, Barmin VS, Riabchikova EI, Popkova NI, Shestopalov AM, Nazarov VP. Zh Mikrobiol Epidemiol Immunobiol; 1994 Apr 18; (3):104-6. PubMed ID: 7941853 [No Abstract] [Full Text] [Related]
48. [Theoretical approaches to the evaluation of antiviral drug effectiveness]. Chermashentsev VM, Zhukov VA, Maríasov AG, Safatov AS. Vestn Ross Akad Med Nauk; 1993 Apr 18; (9):3-7. PubMed ID: 7510180 [Abstract] [Full Text] [Related]
49. [Survival of Marburg virus infectivity on contaminated surfaces and in aerosols]. Belanov EF, Muntianov VP, Kriuk VD, Sokolov AV, Bormotov NI, P'iankov OV, Sergeev AN. Vopr Virusol; 1996 Apr 18; 41(1):32-4. PubMed ID: 8669144 [Abstract] [Full Text] [Related]
54. [A comparative evaluation of an immunoenzyme analytical method using a fluorogenic or chromogenic substrate in determining the Marburg virus antigen]. Kutuzov VA, Mikhaĭlov VV, Kruglova SE, Kutuzov VV, Kirillov AP, Krasnianskiĭ VP, Pshenichnov VA, Lebedinskaia EV. Vopr Virusol; 1993 Apr 18; 38(1):17-8. PubMed ID: 8073738 [Abstract] [Full Text] [Related]
55. The pathology of Marburg virus disease. Rippey JJ, Schepers NJ, Gear JH. S Afr Med J; 1984 Jul 14; 66(2):50-4. PubMed ID: 6539950 [Abstract] [Full Text] [Related]
56. Marburg virus: First cases in Rwanda spark international alarm. Volkmer A. BMJ; 2024 Oct 02; 387():q2155. PubMed ID: 39357913 [No Abstract] [Full Text] [Related]
57. Marburg Vaccine Safe, Immunogenic in Phase 1 Trial. Harris E. JAMA; 2023 Mar 07; 329(9):703. PubMed ID: 36790829 [No Abstract] [Full Text] [Related]
58. [Marburg virus and mononuclear phagocytes: study of interactions]. Skripchenko AA, Riabchikova EI, Vorontsova LA, Shestopalov AM, Viazunov SA. Vopr Virusol; 1994 Mar 07; 39(5):214-8. PubMed ID: 7716905 [Abstract] [Full Text] [Related]